Chronic Rhinosinusitis with Nasal Polyps: Developing Drugs for Treatment : Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 28, 2023
January 31, 2025
439c0f16-253a-4864-95f1-2bc1395e5163
Related Documents
Drug-Drug Interaction Assessment for Therapeutic Proteins Guidance for Industry: Guidance for Industry
Guidance DocumentJune 22, 2023Center for Drug Evaluation and Research
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 24, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.